Beta Bionics Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Beta Bionics · iLet Bionic Pancreas insulin pump · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Beta Bionics
- Product or service
- iLet Bionic Pancreas insulin pump
- Court case number
- 2:26-cv-09999
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead plaintiff application
Participation information
Availability is based on each listed participation option and its deadline.
Lead plaintiff application
Purchasers of Beta Bionics common stock between July 30, 2025 and February 24, 2026, inclusive, may seek appointment as lead plaintiff.
Move the court no later than November 3, 2026. Contact Rosen Law Firm for information about the action.
- Type
- Lead Plaintiff
- Status
- Open
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Beta Bionics Securities Fraud Class Action
Morningstar ·